Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,103 | 45,540 | 112,672 | 112,765 | 49,865 |
| Marketable Securities | 264,277 | 267,281 | 187,594 | 122,922 | 126,212 |
| TOTAL | $348,700 | $332,897 | $321,218 | $250,149 | $185,785 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 5,108 | 18,793 | 29,414 |
| Other Non-Current Assets | 595 | 272 | 229 | 564 | 296 |
| TOTAL | $595 | $272 | $5,337 | $19,357 | $29,710 |
| Total Assets | $349,295 | $333,169 | $326,555 | $269,506 | $215,495 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,727 | 5,934 | 5,933 | 4,060 | 4,364 |
| Accrued Expenses | 16,169 | 19,997 | 15,569 | 15,478 | 8,451 |
| TOTAL | $24,995 | $25,945 | $21,558 | $19,636 | $12,953 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 320 | 0 | 0 | 0 | 0 |
| TOTAL | $320 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $25,315 | $25,945 | $21,558 | $19,636 | $12,953 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,575 | 44,202 | 41,281 | 40,569 | 34,213 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -447,961 | -404,641 | -369,097 | -334,119 | -302,720 |
| Other shareholders' equity | -270 | 14 | 206 | -18 | -17 |
| TOTAL | $323,980 | $307,224 | $304,997 | $249,870 | $202,542 |
| Total Liabilities And Equity | $349,295 | $333,169 | $326,555 | $269,506 | $215,495 |